Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant thyroid-stimulating hormone in differentiated thyroid cancer.

Y Krausz1, B Uziely, R Nesher

  • 1Department of Medical Biophysics and Nuclear Medicine, Hadassah University Hospital, Jerusalem, Israel. yodphat@hadassah.org.il

The Israel Medical Association Journal : IMAJ
|December 4, 2001
PubMed
Summary

Recombinant TSH (rTSH) effectively stimulates thyroid remnant detection in differentiated thyroid cancer patients. It offers similar diagnostic accuracy to hormone withdrawal, avoiding associated morbidities and risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of the Charge-Averaged Elastic Lepton-Proton Scattering Cross Section by the OLYMPUS Experiment.

Physical review letters·2021
Same author

The impact of social complexity on the visual exploration of others' actions in preschoolers with autism spectrum disorder.

BMC psychology·2021
Same author

Key role for liquid biopsy in the elimination of breast cancer surgery following neoadjuvant therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Study of Two-Photon Exchange via the Beam Transverse Single Spin Asymmetry in Electron-Proton Elastic Scattering at Forward Angles over a Wide Energy Range.

Physical review letters·2020
Same author

Circulating breast-derived DNA allows universal detection and monitoring of localized breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

The potential of δ<sup>2</sup>H<sub>n-alkanes</sub> and δ<sup>18</sup>O<sub>sugar</sub> for paleoclimate reconstruction - A regional calibration study for South Africa.

The Science of the total environment·2020

Area of Science:

  • Endocrinology
  • Oncology
  • Nuclear Medicine

Background:

  • Differentiated thyroid cancer management requires monitoring for recurrence.
  • Thyroid hormone suppressive therapy (THST) is standard, necessitating TSH withdrawal for diagnostic testing.
  • THST withdrawal causes hypothyroidism, impacting quality of life and potentially tumor progression.

Purpose of the Study:

  • To evaluate the efficacy and safety of recombinant TSH (rTSH) in differentiated thyroid cancer patients.
  • To compare diagnostic performance of rTSH stimulation versus THST withdrawal.
  • To assess rTSH's role in radioiodine uptake and thyroglobulin testing.

Main Methods:

  • Administration of exogenous rTSH for diagnostic stimulation.
  • Comparison of radioiodine whole-body scan (WBS) and serum thyroglobulin levels post-rTSH versus post-THST withdrawal.

Related Experiment Videos

  • Assessment of patient tolerance and adverse events associated with rTSH.

    • Main Results:

    • rTSH provides similar sensitivity and image quality for WBS compared to THST withdrawal.
    • Serum thyroglobulin measurement after rTSH shows equivalent sensitivity to withdrawal for detecting residual disease.
    • rTSH is well-tolerated, with transient side effects; no specific antibodies were documented.

    Conclusions:

    • Recombinant TSH is an effective alternative to THST withdrawal for diagnostic testing in differentiated thyroid cancer.
    • rTSH avoids the morbidity of hypothyroidism, improving patient quality of life and reducing tumor progression risk.
    • rTSH facilitates sensitive thyroglobulin testing and radioiodine uptake assessment, aiding in patient management.